Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antiphospholipid Antibodies and Early Fetal Growth Restriction (<34 Weeks of Gestation). A Case Control Study.

NCT01538134 is registered in ClinicalTrials.gov with Saint Thomas Hospital, Panama as lead sponsor.

NCT NCT01538134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01538134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antiphospholipid Antibodies and Early Fetal Growth Restriction (<34 Weeks of Gestation). A Case Control Study.
Lead sponsor
Saint Thomas Hospital, Panama
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2015
Completion date
March 31, 2016
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiphospholipid syndrome, fetal growth restriction